It has been proven that a large number of cells (10 million/mouse, equivalent to 1000 functional islets) in a mouse-to-mouse transplantation is needed to correct hyperglycemia in vivo when either the differentiation efficiency or the insulin content was low [21, 31]. The gene discussed is INS; the disease is Hyperglycemia.